R. Robinot
发表
Andrew R. Leach,
Anna Gaulton,
Aurelien Dugourd,
2020,
Cell.
G. Salles,
L. Genestier,
P. Marche,
2018,
Blood.
G. Salles,
L. Genestier,
P. Marche,
2018
.
H. Mouquet,
O. Schwartz,
Mathieu Hubert,
2021,
bioRxiv.
H. Mouquet,
O. Schwartz,
Mathieu Hubert,
2021
.
H. Mouquet,
O. Schwartz,
Mathieu Hubert,
2021,
The EMBO journal.
H. Mouquet,
O. Schwartz,
I. Staropoli,
2022,
bioRxiv.
Y. Yazdanpanah,
P. Morel,
F. Rey,
2020,
medRxiv.
Y. Yazdanpanah,
P. Morel,
F. Rey,
2020,
Science Translational Medicine.
B. Reinius,
T. Mondal,
Nikhil R. Gandasi,
2022,
bioRxiv.
P. Lledo,
D. Duffy,
O. Schwartz,
2020,
bioRxiv.
P. Coursaget,
M. Tognon,
A. Touzé,
2013,
Clinical and Vaccine Immunology.
D. Ho,
K. To,
J. Chan,
2021,
bioRxiv.
P. Coursaget,
M. Tognon,
A. Touzé,
2012,
Emerging infectious diseases.
Vincent Michel,
P. Lledo,
D. Duffy,
2021,
Nature Communications.
J. Izopet,
O. Schwartz,
E. Joly,
2021,
medRxiv.
P. Gaulard,
G. Salles,
J. Lachuer,
2016,
The Journal of experimental medicine.
P. Gaulard,
G. Salles,
S. Mareschal,
2021,
The Journal of clinical investigation.
T. Cokelaer,
M. Hasan,
O. Schwartz,
2022,
Nature Communications.
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
J. Weissman,
M. Vignuzzi,
B. Conklin,
2021,
Nature Cell Biology.
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
J. Weissman,
M. Vignuzzi,
B. Conklin,
2021,
Nature cell biology.
T. Cokelaer,
M. Hasan,
O. Schwartz,
2022,
Nature communications.
A. Fontanet,
B. Hoen,
H. Mouquet,
2020,
Cell Reports Medicine.
D. Planas,
I. Staropoli,
F. Boufassa,
2023,
Frontiers in immunology.
K. To,
K. Yuen,
Xinquan Wang,
2023,
Emerging microbes & infections.